MOBIX LABS, INC (MOBX): Nasdaq/NYSE listing notice — Chavant Capital receives Nasdaq delisting notice for MVLS below $35M

MOBIX LABS, INC

On March 23, 2023, Nasdaq notified Chavant that for 30 consecutive business days MVLS of ordinary shares was below $35 million.
Company also fails alternative listing standards: shareholders' equity < $2.5M or net income < $500K.
Chavant has until September 19, 2023 to regain compliance by achieving MVLS >= $35M for 10 consecutive business days.
If not compliant by deadline, Nasdaq will delist ordinary shares; company may appeal.
Securities continue trading on Nasdaq Capital Market during 180-day compliance period.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

MOBIX LABS, INC received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

March 23, 2023, Chavant Capital Acquisition Corp. (the “Company”) received a notice from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, for the previous 30 consecutive business days, the minimum Market Value of Listed Securities (“MVLS”) for the Company’s ordinary shares was below the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MLVS Rule”). Additionally, as of the date of this Form 8-K, the Company does not meet either of the alternative Nasdaq continued listin

View on SEC.gov

Browse all listing & compliance notices →

MOBIX LABS, INC filing history →

Source: SEC EDGAR

accession 0001104659-23-038322

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.